Merck MRK will report its first-quarter 2024 earnings on April 24, before market open. The Zacks Consensus Estimate for first ...

Not only are pharmaceutical stocks excellent defensive investments, some pharma stocks pay sizable dividends that can be a ...

Merck is growing pharma sales and expanding margins, led by strong KEYTRUDA performance and cost discipline. Read more about ...

Merck, Black Hills, and Virtus Investment Partners are good choices for investors seeking reliable passive income. Their ...

We recently published a list of 15 Best Large-Cap Value Stocks to Buy as the Recession Hits. In this article, we are going to ...

a global pharmaceutical company focusing on scientific and technological innovation, announced on March 25 that it has entered into an exclusive license agreement with United States-based Merck, ...

Takeda Pharmaceutical Trading Up 0.8 % Shares of Takeda Pharmaceutical stock opened at $15.15 on Friday. Takeda Pharmaceutical Company Limited has a 1 year low of $12.58 and a 1 year high of $15. ...

a global pharmaceutical company focusing on scientific and technological innovation, announced on March 25 that it has entered into an exclusive license agreement with United States-based Merck ...

RAHWAY, N.J. - Merck & Co., Inc. (NYSE: MRK), a global healthcare leader, has announced an exclusive licensing agreement with Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma), a company ...

March 25 (Reuters) - Merck (MRK.N), opens new tab has signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals ... as the company prepares to participate in ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Software group SAP has overtaken Danish drugmaker Novo Nordisk to become Europe’s most valuable company ...